INS and systemic primary carnitine deficiency disease: In addition, carnitine deficiency in this model of diabetes is a factor linked to a reduction in glucose use, a metabolic aberration accompanied by increased ischemic injury to the heart and peripheral insulin resistance [27,28,29].